Delivery Order SPE2DB24D1021-SPE2DB25FEWAC

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.44, is a firm fixed-price delivery order for 4,568,105,655 units of the pharmaceutical product ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.45, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,399.48, is for the delivery of 4567684697 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,564,575 ONFI 10 MG TABLET 100S. The contract has a ceiling value of $4,960.15 and a completion date of August 26, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,707.35 firm-fixed-price contract is for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999, to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $9,313.73 and a performance period extending through June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,255.38 firm-fixed price contract is for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $8,510.23 and a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $11,606.49 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. The contract has an ultimate completion date of May 14, 2025....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,361.34, is for the delivery of 4566338484 ONFI 10 MG TABLET 100S. It is a firm fixed price contract with a period of performance through November 6, 2024. The contract was not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEWAC
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,385.21, is for the delivery of 4,567,954,743 units of the medication ONFI 10 MG TABLET 100S. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract supports the DLA's mission to provide medical supplies and pharmaceuticals to the U.S. military and other government agencies.

Generated 7/17/25, 2:11 PM